Wegovy Guide (2026)
FDA-approved semaglutide 2.4mg for chronic weight management. Average weight loss: 15% in clinical trials.
15%
Avg Weight Loss
N/A
Compounded Price
Weekly
Injection Frequency
5
Dose Options
What Is Wegovy?
Wegovy is a Brand-name semaglutide for weight loss that works by fda-approved semaglutide 2.4mg for chronic weight management. It was approved by the FDA in June 2021 and is manufactured by Novo Nordisk. In clinical trials (STEP 1), patients achieved an average weight loss of 15% of their body weight.
Brand names include Wegovy. Wegovy is administered as a weekly subcutaneous injection, making it convenient for most patients.
How Wegovy Works
FDA-approved semaglutide 2.4mg for chronic weight management. This dual action of reducing hunger and improving metabolic function makes Wegovy one of the most effective weight loss medications available today.
Who Should Consider Wegovy?
Wegovy is prescribed for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition. A licensed healthcare provider will evaluate your eligibility based on your medical history, current medications, and weight loss goals.
Wegovy FAQ
How much does Wegovy cost?
Compounded Wegovy costs N/A through telehealth providers. Brand-name versions (Wegovy) cost $1,300+/mo without insurance.
How much weight can I lose on Wegovy?
Clinical trials show an average weight loss of 15% of body weight on Wegovy. Individual results vary based on dosage, diet, and exercise habits.
What are Wegovy side effects?
Common side effects include nausea, diarrhea, constipation, vomiting, headache. Most side effects are temporary and resolve within 4-8 weeks as your body adjusts.
Is Wegovy taken daily or weekly?
Wegovy is administered as a weekly subcutaneous injection. It uses a pre-filled pen device for subcutaneous injection.
What doses is Wegovy available in?
Wegovy is available in 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg doses. Treatment starts at the lowest dose and increases every 4 weeks.